SCHEMBL8512933

SCHEMBL8512933

O=C(O)N1CCC(OCc2ccnc(Cl)c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.44
FAAH O00519 1/20 0.44
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
RECQL P46063 1/20 0.41
EPHX1 P07099 1/20 0.40
BCHE P06276 4/20 0.39
MGMT P16455 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
LOX P28300 1/20 0.38
LOXL3 P58215 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
MMP1 P03956 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495622 0.82 CARM1 (0.45) RECQLMGMTHRH3LOXLOXL3
SCHEMBL23012636 0.82 CARM1 (0.45) RECQLMGMTHRH3LOXLOXL3
SCHEMBL29277066 0.81 ITGB3 (0.47) MGLLFAAHGRIN2DGRIN3BGRIN1
SCHEMBL3980273 0.81 GRM2 (0.46) MGLLFAAHMAPTHTTGRIN2D
SCHEMBL2661814 0.78 EPHX2 (0.44)
SCHEMBL20569837 0.78 MGLL (0.41) MGLLFAAHHTTGRIN2DGRIN3B
SCHEMBL16377422 0.77 ECE2 (0.42) RECQLEPHX1LOXLOXL3LOXL2
SCHEMBL8511962 0.76 SLC6A4 (0.54) RECQLMGMTLOXLOXL3LOXL2
SCHEMBL16600153 0.75 DRD4 (0.55) MGLLFAAHGRIN2DGRIN3BGRIN1
SCHEMBL2523420 0.74 CARM1 (0.58) MGLLFAAHGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US disclosed
EP-2643311-A1 BICYCLIC GPR119 MODULATORS Lupin Limited (IN) 2013-10-02 EP disclosed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US disclosed
WO-2012069917-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245000-A1 BICYCLIC GPR119 MODULATORS GPR119, GPR180, GPBAR1 MGLL 1214/4885FAAH 768/4885MAPT 4305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.